反応 #76631
ord-943b2b930a5e4df58d4e009d6b0befad
反応方程式
反応物
試薬
反応条件
後処理
- 1workup.STIRRINGstirring
- 2workup.WAITwas continued for a further 30 minutes at −10° C.
- 3workup.ADDITIONbefore being added to a solution
- 4workup.STIRRINGThe resulting mixture was stirred at −78° C. for 2 hours
- 5温度then warmed to −30° C.
- 6洗浄The organic phase was washed twice with water
- 7乾燥dried over magnesium sulphate
- 8ろ過filtered
- 9その他evaporated to dryness
- 10その他The residue was chromatographed on silica gel
- 11洗浄for the elution
- 12workup.DISSOLUTIONThe product was dissolved in 1 ml of ethyl acetate
- 13workup.WAIT10 ml of diethyl ether and left
- 14その他to crystallize
実験手順
100 mg (2.5 mmol) of 60% sodium hydride disperion in mineral oil were added to a solution of 728 mg (2.2 mmol) of (E)-5-(3,4-dichlorostyryl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one in 5 ml of anhydrous dimethylformamide at room temperature under a nitrogen atmosphere and stirred for 30 minutes. The mixture was cooled to −20° C., 431 mg (2.5 mmol) of diethyl chlorophosphate were added and stirring was continued for a further 30 minutes at −10° C. before being added to a solution prepared by addition of 1.65 ml (3.3 mmol) of 2M lithium diisopropylamide to a solution of 375 mg (3.32 mmol) of ethyl isocyanoacetate in 5 ml of anhydrous tetrahydrofuran at −78° C. under a nitrogen atmosphere. The resulting mixture was stirred at −78° C. for 2 hours then warmed to −30° C. and 180 mg (3 mmol) of acetic acid were added followed by water and ethyl acetate. The organic phase was washed twice with water, dried over magnesium sulphate, filtered and evaporated to dryness. The residue was chromatographed on silica gel using ethyl acetate/methanol (49:1) for the elution. The product was dissolved in 1 ml of ethyl acetate and 10 ml of diethyl ether and left to crystallize. There was obtained 116 mg of ethyl (E)-6-(3,4-dichlorostyryl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as a light-brown solid. MS: m/e 425.9 [M+H]+.